Table 1 Patient and tumor characteristics in relation to the type of performed surgical procedure
From: Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade
Treatment characteristics of all included patients | Total, n = 556 | LH, n = 248 | AH, n = 308 | p value |
|---|---|---|---|---|
Age in years (mean, SD) | 65.8 (9.6) | 65.3 (9.8) | 66.4 (9.4) | 0.166 |
BMI (mean, SD) | 29.6 (6.7) | 29.8 (7.0) | 29.3 (6.3) | 0.429 |
Parity (mean, SD) | 2.0 (1.4) | 2.03 (1.4) | 2.02 (1.3) | 0.909 |
Previous abdominal surgery | 184 | 80 | 104 | 0.585 |
Comorbidity | ||||
Hypertension | 178 | 77 | 101 | 0.582 |
Type II diabetes | 83 | 30 | 53 | 0.093 |
FIGO stage | 0.364 | |||
IA | 336 | 158 | 178 | |
IB | 195 | 80 | 115 | |
II | 25 | 10 | 15 | |
Histology | 0.002 | |||
Endometrioid | 502 | 231 | 271 | |
Non-endometrioid | ||||
Serous | 28 | 15 | 13 | |
Clear cell | 8 | 2 | 6 | |
Carcinosarcoma | 15 | 0 | 15 | |
Stromal cell sarcoma | 3 | 0 | 3 | |
Tumor grade | 0.000 | |||
1 | 279 | 151 | 128 | |
2 | 175 | 63 | 112 | |
3 | 102 | 34 | 68 | |
Treatment | ||||
Hysterectomy and BSO | 556 | 305 | 241 | 0.196 |
Additional staging/lymphadenectomy | 80 | 10 | 70 | 0.000 |
Conversion to laparotomy | 19 | 19 | – | |
Duration of surgery, min (mean, SD) | 101 (41.9) | 116 (39.3) | 90 (40.4) | 0.204 |
Complications | ||||
During surgery | 26 | 19 | 7 | 0.004 |
After surgery | 30 | 6 | 24 | 0.005 |